Analyst firms · Leerink Partners · PRTC

Leerink Partners PRTC price target and rating history

PureTech Health plc (PRTC) · Health Care

Leerink Partners rates PureTech Health plc (PRTC) Outperform with a $45 price target, as of its latest action on Sep 9, 2024. It has published 3 rating actions on PRTC since August 2021, including 0 upgrades and 0 downgrades.

Current rating
Outperform
Price target
$45
Median target, all firms
Too few
Actions on PRTC
3

Leerink Partners price target on PRTC

$76$61$4520222023202420252026
Leerink Partners price target on PRTC, each point a stated target, August 2021 to September 2024.

Every Leerink Partners rating on PRTC

Questions about Leerink Partners and PRTC

What is Leerink Partners's price target for PRTC?
Leerink Partners's latest stated price target for PureTech Health plc (PRTC) is $45, from its action on Sep 9, 2024.
What is Leerink Partners's rating on PRTC?
Leerink Partners rates PRTC Outperform, a bullish rating, as of Sep 9, 2024.
When did Leerink Partners last change its view on PRTC?
On Sep 9, 2024, Leerink Partners resumes coverage at Outperform, price target $58 to $45.

All Leerink Partners ratingsPRTC news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.